Theophylline Treatment for Pseudohypoparathyroidism
Theophylline Treatment for Pseudohypoparathyroidism
Active, not recruiting · NCT03029429 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Theophylline Treatment for Pseudohypoparathyroidism | Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, bone disorder, calcium metabolic disease, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease, musculoskeletal system disorder, pseudohypoparathyroidism | Active, not recruiting | Phase 2 | 2026-09-02 | NCT03029429 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Harvard University | 37 |
| Vanderbilt University Medical Center | 299 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jaclyn Tamaroff | Nashville | United States | 1 |